Bakterielle Vaginose und Fluomizin



  1. 1.
    Weissenbacher ER, Donders G, Unzeitig V et al (2012) A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest 73:8–15CrossRefPubMedGoogle Scholar
  2. 2.
    National Guideline For The Management Of Bacterial Vaginosis. Clinical Effectiveness Group. British Association for Sexual Health and HIV, 2006 Google Scholar
  3. 3.
    Sobel JD (2000) Bacterial vaginosis. Annu Rev Med 51:349–356CrossRefPubMedGoogle Scholar
  4. 4.
    Morbidity and Mortality Weekly Report. Recommendations and Reports. May 10, 2002/Vol. 51/No. RR-6/Page 42. Google Scholar
  5. 5.
    Grishchenko OV, Lakhno IV, Dudko VL et al (2006) Clinical and prognostic aspects of bacterial vaginosis treatment in pregnant women. Women Health 3:Google Scholar
  6. 6.
    Petersen EE, Weissenbacher ER, Hengst P et al (2002) Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clincical study. Arzneimittelforschung 52:706–715PubMedGoogle Scholar
  7. 7.
    Fachinformation Fluomizin. Google Scholar
  8. 8.
    Leitlinie „Bakterielle Vaginose in Gynäkologie und Geburtshilfe“ der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V., 2013. Google Scholar
  9. 9.
    Sherrard J, Wilson J, Donders G et al (2018) 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J Std Aids. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2018

Personalised recommendations